Vaccine/Toxoid
(click on link
for CDC VIS) | Event
(click on link for definitions) | Interval from Vaccination
(click on link for inserts) |
Tetanus in any combination;
DTaP, DTP, DTP-HiB, DT, Td, or TT) | A. Anaphylaxis or anaphylactic shock | 7 days |
| B. Brachial neuritis | 28 days |
| C. Any sequelae (including death) of above events | Not applicable |
| D. Events described in manufacturer's package insert as contraindications to additional doses of vaccine | See package insert |
| Pertussis in any combination; DTaP, DTP, DTP-HiB, P | A. Anaphylaxis or anaphylactic shock | 7 days |
| B. Encephalopathy (or encephalitis) | 7 days |
| C. Any sequelae (including death) of above events | Not applicable |
| D. Events described in manufacturer's package insert as contraindications to additional doses of vaccine | See package insert |
| Measles, mumps and rubella in any combination; MMR, MR, M, or R | A. Anaphylaxis or anaphylactic shock | 7 days |
| B. Encephalopathy (or encephalitis) | 15 days |
| C. Any sequelae (including death) of above events | Not applicable |
| D. Events described in manufacturer's package insert as contraindications to additional doses of vaccine | See package insert |
| Rubella in any combination; MMR, MR, R | A. Chronic arthritis | 42 days |
| B. Any sequelae (including death) of above event | Not applicable |
| C. Events described in manufacturer's package insert as contraindications to additional doses of vaccine | See package insert |
| Measles in any combination; MMR, MR, M | A. Thrombocytopenic purpura | 7-30 days |
| B. Vaccine-strain measles viral infection in an immunodeficient recipient | 6 months |
| C. Any sequelae (including death) of above event | Not applicable |
| D. Events described in manufacturer's package insert as contraindications to additional doses of vaccine | See package insert |
| Oral Polio (OPV) | A. Paralytic polio | 30 days/ 6 months |
| B. Vaccine-strain polio viral infection | 30 days/ 6 months |
| C. Any sequelae (including death) of above events | Not applicable |
| D. Events described in manufacturer's package insert as contraindications to additional doses of vaccine | See package insert |
| Inactivated Polio (IPV) | A. Anaphylaxis or anaphylactic shock | 7 days |
| B. Any sequelae (including death) of the above event | Not applicable |
| C. Events described in manufacturer's package insert as contraindications to additional doses of vaccine | See package insert |
| Hepatitis B | A. Anaphylaxis or anaphylactic shock | 7 days |
| B. Any sequelae (including death) of the above event | Not applicable |
| C. Events described in manufacturer's package insert as contraindications to additional doses of vaccine | See package insert |
| Hemophilus influenzae, Type b, (conjugate) | A. Events described in manufacturer's package insert as contraindications to additional doses of vaccine | See package insert |
| Varicella | A. Events described in manufacturer's package insert as contraindications to additional doses of vaccine | See package insert |
| Rotavirus | A. Intussusception | 30 days |
| B. Any sequela (including death) of the above event | Not applicable |
| C. Events described in manufacturer's package insert as contraindications to additional doses of vaccine | See package insert |
| Pneumococcal conjugate | A. Events described in manufacturer's package insert as contraindications to additional doses of vaccine | See package insert |
